Physician profile
Fred M Sutton
NPI 1295815538
$1,592.26
in general payments reported to CMS, 2019-2025
15 companies · $294 in 2025
The $294 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $129 · 2020: $28.76 · 2021: $53.14 · 2022: $188 · 2023: $565 · 2024: $335 · 2025: $294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,193.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $319.53 | 2021-2025 | Renflexis, Hadlima, Nexplanon |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $275.35 | 2019-2025 | Xifaxan |
| Takeda Pharmaceuticals U.S.A., INC. | $256.04 | 2019-2025 | Entyvio, Gattex |
| Abbvie INC. | $237.96 | 2019-2025 | Rinvoq, Viberzi, Linzess |
| Madrigal Pharmaceuticals | $159.41 | 2024-2025 | Rezdiffra, Resmetirom |
| Janssen Biotech, INC. | $104.68 | 2019-2025 | Stelara, Tremfya |
| Intercept Pharmaceuticals, INC. | $48.87 | 2020-2024 | Ocaliva |
| Merck Sharp & Dohme LLC | $44.73 | 2019-2023 | Dificid |
| Celgene Corporation | $34.13 | 2023 | Zeposia |
| Ipsen Biopharmaceuticals, INC | $27.59 | 2023 | Bylvay |
| Orphalan INC | $24.57 | 2023 | Cuvrior |
| Gilead Sciences, INC. | $22.83 | 2024 | Epclusa |
| Qol Medical, LLC | $20.76 | 2022 | |
| Shionogi INC | $15.81 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fred Sutton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.